NovaBay Pharmaceuticals Inc (NBY)
0.0773
0.00 (0.00%)
USD |
NYAM |
Apr 25, 16:00
0.0773
0.00 (0.00%)
After-Hours: 20:00
NovaBay Pharmaceuticals Free Cash Flow: -4.15M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.15M |
| September 30, 2023 | -5.043M |
| June 30, 2023 | -6.447M |
| March 31, 2023 | -6.309M |
| December 31, 2022 | -6.766M |
| September 30, 2022 | -9.883M |
| June 30, 2022 | -9.599M |
| March 31, 2022 | -9.881M |
| December 31, 2021 | -9.244M |
| September 30, 2021 | -6.384M |
| June 30, 2021 | -6.274M |
| March 31, 2021 | -5.326M |
| December 31, 2020 | -4.747M |
| September 30, 2020 | -4.71M |
| June 30, 2020 | -4.835M |
| March 31, 2020 | -5.578M |
| December 31, 2019 | -7.948M |
| September 30, 2019 | -8.543M |
| June 30, 2019 | -8.669M |
| March 31, 2019 | -8.381M |
| December 31, 2018 | -5.612M |
| September 30, 2018 | -6.53M |
| June 30, 2018 | -4.696M |
| March 31, 2018 | -4.915M |
| December 31, 2017 | -6.514M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.874M |
| June 30, 2017 | -7.971M |
| March 31, 2017 | -8.937M |
| December 31, 2016 | -11.82M |
| September 30, 2016 | -16.08M |
| June 30, 2016 | -16.36M |
| March 31, 2016 | -19.11M |
| December 31, 2015 | -18.68M |
| September 30, 2015 | -18.26M |
| June 30, 2015 | -16.89M |
| March 31, 2015 | -15.22M |
| December 31, 2014 | -15.12M |
| September 30, 2014 | -15.76M |
| June 30, 2014 | -15.38M |
| March 31, 2014 | -13.84M |
| December 31, 2013 | -13.11M |
| September 30, 2013 | -11.52M |
| June 30, 2013 | -8.901M |
| March 31, 2013 | -7.641M |
| December 31, 2012 | -6.676M |
| September 30, 2012 | -4.077M |
| June 30, 2012 | -3.504M |
| March 31, 2012 | -5.896M |
| December 31, 2011 | -3.261M |
| September 30, 2011 | -0.61M |
Free Cash Flow Range, Past 5 Years
-9.883M
Minimum
Sep 2022
-4.15M
Maximum
Dec 2023
-6.860M
Average
-6.384M
Median
Sep 2021
Free Cash Flow Benchmarks
| Eyenovia Inc | -27.81M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
| Oragenics Inc | -7.291M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.314M |
| Cash from Investing (Quarterly) | -0.002M |
| Cash from Financing (Quarterly) | -0.026M |
| Free Cash Flow Per Share (Quarterly) | -0.0281 |
| Free Cash Flow to Equity (Quarterly) | -0.183M |
| Free Cash Flow Yield | -1.02K% |